Detailed price information for Compass Therapeutics Inc (CMPX-Q) from The Globe and Mail including charting and trades.
Acquisition increases Tres Cerros concessions by ~52% to 3,310 hectares and extends Tres Cerros corridor ~5 kilometres to the ...
Summit Therapeutics Inc. (NASDAQ: SMMT) today announced it has entered into a clinical trial collaboration with GSK plc ("GSK ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback